Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Collaboration › Details

Bruker–Leerink: investor conference, 201802 supply service Bruker to present at Leerink Partners Global Healthcare Conference 2018

	Period	2018-02-14
	Region	New York, NY
	Country	United States (USA)
	Successor	Bruker–SVB: investor conference, 201902 supply service Bruker presents at SVB Leerink Global Healthcare Conference
	Partner, 1st	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Partner, 2nd	Leerink Partners LLC [old]
	Today	Leerink Partners (Group)
	Group	Leerink Partners (Group)
	Product	Leerink Partners Annual Global Healthcare Conference 2018 New York
	Product 2	analytical instrument
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations)

Bruker Corporation. (2/9/18). "Press Release: Bruker Corporation to Present at the Leerink Partners 7th Annual Global Healthcare Conference". Billerica, MA.

Bruker Corporation (NASDAQ: BRKR) announced today it will present at the LEERINK Partners 7th Annual Global Healthcare Conference. Frank Laukien, President and CEO, will participate in a "fireside chat" Q&A session on behalf of the company on Wednesday, February 14th, 2018 at 9:30 AM Eastern Time.

A live audio webcast of the presentation will be available on the Investor section of the Company's website at http://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation website after the event and will be available for 30 days following the presentation.

About Bruker Corporation

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, microbiology and molecular pathology research. For more information, please visit: www.bruker.com.

Contact:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com